Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1350.20
11.70
(0.87%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr. Reddy’s Lab soars on receiving EIR from USFDA for Medak units
>>
Dr. Reddy’s Lab receives EIR from USFDA for Medak units
>>
Dr. Reddy’s Lab loses patent case with Eli Lilly
>>
Dr. Reddy’s Laboratories informs about press release
>>
Dr. Reddy’s launches Levetiracetam in Sodium Chloride Injection in US Market
>>
Dr. Reddy’s Lab trades in green on the bourses
>>
Dr Reddys Laboratories informs about press release
>>
Dr. Reddy’s Lab soars on receives approval for Buprenorphine and Naloxone Sublingual Film
>>
Dr. Reddy’s Lab receives approval for Buprenorphine and Naloxone Sublingual Film
>>
Dr. Reddy’s shines on expecting to launch generic version of Copaxone in H1FY20
<<
<
79
80
81
...145
>
>>